JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.17% |
| 2 | Financials | 10.11% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 7.97% |
| 5 | Communication Services | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Pegasystems
PEGA
$5.51B
| $22.7M | ﹤0.01% |
486,520
-42,220
| -8% | -$1.81M |
|
1902
PUT
Kraft Heinz
KHC
$30.1B
| $22.6M | ﹤0.01% |
737,100
+79,700
| +12% | +$2.61M |
|
1903
Integer Holdings
ITGR
$4.25B
| $22.6M | ﹤0.01% |
170,733
+100,811
| +144% | +$13.4M |
|
1904
Enact Holdings
ACT
$6.84B
| $22.6M | ﹤0.01% |
697,248
+5,244
| +0.8% | +$181K |
|
1905
BorgWarner
BWA
$13.8B
| $22.6M | ﹤0.01% |
709,740
-135,006
| -16% | -$4.6M |
|
1906
Valley National Bancorp
VLY
$8.3B
| $22.5M | ﹤0.01% |
2,485,474
+991,084
| +66% | +$9.61M |
|
1907
Insperity
NSP
$2.05B
| $22.5M | ﹤0.01% |
290,166
+139,497
| +93% | +$11.3M |
|
1908
Invesco
IVZ
$14.3B
| $22.5M | ﹤0.01% |
1,285,609
+188,041
| +17% | +$3.35M |
|
1909
Simmons First National
SFNC
$3.46B
| $22.4M | ﹤0.01% |
1,011,431
+335,260
| +50% | +$7.84M |
|
1910
FormFactor
FORM
$10.3B
| $22.4M | ﹤0.01% |
509,399
+275,824
| +118% | +$11.9M |
|
1911
Incyte
INCY
$24.4B
| $22.4M | ﹤0.01% |
323,640
+38,550
| +14% | +$2.75M |
|
|
SNV
1912
DELISTED
Synovus
SNV
| $22.3M | ﹤0.01% |
435,543
+72,745
| +20% | +$3.77M |
|
1913
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.46B
| $22.3M | ﹤0.01% |
538,883
+69,160
| +15% | +$2.89M |
|
|
AVDX
1914
DELISTED
AvidXchange
AVDX
| $22.3M | ﹤0.01% |
2,156,792
-1,280,242
| -37% | -$12.5M |
|
1915
Protagonist Therapeutics
PTGX
$9.8B
| $22.3M | ﹤0.01% |
576,977
+73,992
| +15% | +$3.23M |
|
1916
Brown-Forman Class B
BF.B
$12.9B
| $22.3M | ﹤0.01% |
586,187
-886,556
| -60% | -$39M |
|
1917
Telephone and Data Systems
TDS
$4.03B
| $22.3M | ﹤0.01% |
652,603
+194,136
| +42% | +$5.91M |
|
1918
NorthWestern Energy
NWE
$4.4B
| $22.2M | ﹤0.01% |
415,165
-103,647
| -20% | -$5.63M |
|
1919
Tanger
SKT
$4.42B
| $22.2M | ﹤0.01% |
650,060
+205,159
| +46% | +$7.15M |
|
1920
iShares MSCI Chile ETF
ECH
$1.03B
| $22.2M | ﹤0.01% |
885,948
-110,436
| -11% | -$2.85M |
|
1921
Albemarle
ALB
$15.4B
| $22.1M | ﹤0.01% |
257,316
-372,471
| -59% | -$37.1M |
|
1922
SLR Investment Corp
SLRC
$711M
| $22.1M | ﹤0.01% |
1,368,250
+31,839
| +2% | +$506K |
|
1923
TKO Group
TKO
$14.6B
| $22.1M | ﹤0.01% |
155,556
-137,098
| -47% | -$17.9M |
|
1924
CALL
Starbucks
SBUX
$124B
| $22.1M | ﹤0.01% |
242,200
+14,000
| +6% | +$1.35M |
|
1925
CALL
ServiceNow
NOW
$132B
| $22.1M | ﹤0.01% |
104,000
+41,000
| +65% | +$8.31M |
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 510 new, 3,353 increased, 2,466 reduced and 523 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 510 new positions and closed 523 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.